Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Clinical trial NCT02961374 · COMPLETED
Trial details
- NCT number
- NCT02961374
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2020-02-23
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.